Our findings that SERPINB3 modulated the crosstalk between immune cells and cancer cells via secretion of CXCL1/8 and S100A8/A9 implicate this protease inhibitor member of the SERPIN superfamily in a key tumor strategy of evading antitumor immune responses and resisting therapies such as radiation. Here, CXCL1 is linked to neoplasm.